XML 70 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues:      
Leases $ 5.7    
Total revenues 1,049.3 $ 1,117.5 $ 1,773.6
Operating expenses:      
Cost of goods and services sold 705.4 693.1 748.1
Goodwill impairment 218.2 6.7 41.7
Impairment of long-lived assets 306.7 0.0 0.0
Research and development 111.4 188.3 235.2
Selling, general and administrative 368.4 339.5 348.7
Amortization of intangible assets 65.6 59.9 58.5
Total operating expenses 1,775.7 1,287.5 1,432.2
Income (loss) from operations (726.4) (170.0) 341.4
Other income (expense):      
Interest expense (87.9) (37.3) (34.5)
Gain on sale of business 74.2 0.0 0.0
Other, net 8.9 (11.7) (3.7)
Total other income (expense), net (4.8) (49.0) (38.2)
Income (loss) before income taxes (731.2) (219.0) 303.2
Income tax provision (benefit) 29.3 (7.4) 83.7
Net income (loss) $ (760.5) $ (211.6) $ 219.5
Net income (loss) per common share      
Basic (in dollars per share) $ (14.85) $ (4.22) $ 4.10
Diluted (in dollars per share) $ (14.85) $ (4.22) $ 4.06
Weighted average shares outstanding      
Basic (in shares) 51.2 50.1 53.5
Diluted (in shares) 51.2 50.1 54.1
Total Product sales, net      
Revenues:      
Product sales $ 944.5 $ 966.2 $ 1,023.9
Commercial Product sales      
Revenues:      
Product sales 497.3 386.6 438.0
Operating expenses:      
Cost of goods and services sold 210.3 160.3 187.2
MCM Product sales      
Revenues:      
Product sales 447.2 579.6 585.9
Operating expenses:      
Cost of goods and services sold 305.6 264.3 195.4
Total Bioservices revenues      
Revenues:      
Total Bioservices revenues 78.5 109.9 615.5
Operating expenses:      
Cost of goods and services sold 189.5 268.5 365.5
Services      
Revenues:      
Product sales 72.8 105.0 310.3
Leases      
Revenues:      
Leases 5.7 4.9 305.2
Contracts and grants      
Revenues:      
Product sales $ 26.3 $ 41.4 $ 134.2